Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer
Results
Phase 3
This trial looked at adding nimorazole to radiotherapy to improve treatment for certain types of head and neck cancer.
It was for people with cancer that may have spread into surrounding tissues but no further.
You pronounce nimorazole as nim-o-ra-zol.
The trial was open for people to join between 2014 and 2019. The team published the results in 2023.
Cancer Research UK supported this trial.
Recruitment start: 21 May 2014
Recruitment end: 23 May 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Thomson
Azanta
Cancer Research UK
NIHR Clinical Research Network: Cancer
The Christie NHS Foundation Trust
The Manchester Clinical Trials Unit
This Cancer Research UK trial number CRUK/13/006.
Last reviewed: 20 Mar 2024
CRUK internal database number: 10876